Viridian Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACLX
Arcellx, Inc. |
$67.13 | $2.72 B | -49.3 | 130 | $110.32 M |
BPMC
Blueprint Medicines Corporation |
$103.88 | $6.47 B | -21.48 | 638 | $249.38 M |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$36.42 | $3.53 B | -11.86 | 290 | $4.01 M |
CYTK
Cytokinetics, Incorporated |
$47.02 | $6.05 B | -9.78 | 423 | $7.53 M |
DICE
DICE Therapeutics, Inc. |
$47.55 | $2.27 B | -21.91 | 71 | $0 |
ETNB
89bio, Inc. |
$6.09 | $796.91 M | -4.05 | 70 | $0 |
GPCR
Structure Therapeutics Inc. |
$27.00 | $2.47 B | -23.59 | 136 | $0 |
ICVX
Icosavax, Inc. |
$15.31 | $769.04 M | -6.96 | 60 | $582,000 |
INZY
Inozyme Pharma, Inc. |
$1.37 | $286.39 M | -3.43 | 59 | $0 |
KURA
Kura Oncology, Inc. |
$7.18 | $1.66 B | -10.03 | 142 | $0 |
MRUS
Merus N.V. |
$39.66 | $3.50 B | -19.38 | 172 | $43.95 M |
NUVL
Nuvalent, Inc. |
$76.08 | $5.11 B | -32.72 | 127 | $0 |
PCVX
Vaxcyte, Inc. |
$87.82 | $7.72 B | -16.54 | 254 | $0 |
PLRX
Pliant Therapeutics, Inc. |
$11.63 | $672.63 M | -3.9 | 166 | $1.58 M |
PTGX
Protagonist Therapeutics, Inc. |
$36.59 | $2.04 B | 13.7 | 126 | $60.00 M |
REPL
Replimune Group, Inc. |
$10.42 | $485.18 M | -2.44 | 331 | $0 |
RVMD
Revolution Medicines, Inc. |
$39.89 | $6.66 B | -10.51 | 490 | $11.58 M |
SNDX
Syndax Pharmaceuticals, Inc. |
$13.00 | $1.66 B | -6.02 | 184 | $0 |
TERN
Terns Pharmaceuticals, Inc. |
$4.51 | $462.44 M | -5.67 | 66 | $0 |